News
Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug’s blockbuster potential in the company’s ...
Eli Lilly has spent recent years reintroducing itself to the public via a series of corporate campaigns, and its latest push goes a step further.
Eli Lilly LLY 0.62% agreed to acquire Verve Therapeutics VERV -0.27% for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio. Under the agreement ...
Marketing Lilly enlists ‘Modern Family’ star for musical Mounjaro campaign By Andrea Park May 2, 2025 2:34pm Eli Lilly Mounjaro Type 2 diabetes celebrity spokespeople ...
If Eli Lilly’s latest ad is any indication, the drugmaker wants to differentiate itself from other pharma giants. How it intends to do so is by showcasing the company’s values and recruiting top ...
INDIANAPOLIS and WEST LAFAYETTE, May 9, 2025 — Eli Lilly and Company (NYSE: LLY) and Purdue University announced Friday (May 9) a significant expansion of their long-standing alliance, with Lilly’s ...
Eli Lilly & Co.’s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug’s blockbuster potential in the company’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results